Heather Bresch, defending her company against criticism for sharply increasing the price of EpiPens, is unapologetic. “I am running a business,” she says.
KATIE THOMAS, NY Times: Business
Fri, 08/26/2016 - 2:00am
Heather Bresch, defending her company against criticism for sharply increasing the price of EpiPens, is unapologetic. “I am running a business,” she says.